5-HTP
5-HTP can raise serotonin synthesis and add to levomilnacipran's serotonergic activity.
Recommendation: Avoid 5-HTP while taking levomilnacipran.
Prescription ·Strong evidence ·Reviewed May 2026
Levomilnacipran is an extended-release SNRI approved for major depressive disorder in adults. Compared with many SNRIs it has prominent norepinephrine reuptake inhibition, so blood pressure, heart rate, urinary hesitation, and activation symptoms require attention. It carries the antidepressant boxed warning for suicidal thoughts and behaviors in pediatric and young adult patients.
The bottom line
Evidence rating strong. Most-documented uses: treatment of major depressive disorder in adults, improvement in depressed mood and low motivation, once-daily extended-release administration. 3 sources indexed (2005–2024), with 4 interaction records on file.
Core mechanism
Levomilnacipran inhibits reuptake of norepinephrine and serotonin, increasing monoaminergic signaling in CNS pathways involved in mood and motivation. It has greater norepinephrine than serotonin reuptake inhibition in vitro. It is metabolized partly by CYP3A4 and eliminated substantially by the kidney, so severe renal impairment and strong CYP3A4 inhibitors require dose limits.1,2
Can be taken with or without food. Capsules should be swallowed whole and not opened, crushed, or chewed.3
5-HTP can raise serotonin synthesis and add to levomilnacipran's serotonergic activity.
Recommendation: Avoid 5-HTP while taking levomilnacipran.
Supplemental L-Tryptophan increases serotonin precursor availability and may increase serotonin syndrome risk with levomilnacipran.
Recommendation: Avoid L-Tryptophan supplements during therapy.
St. John's Wort can increase serotonergic activity and can induce drug-metabolizing pathways.
Recommendation: Do not combine St. John's Wort with levomilnacipran.
Levomilnacipran may increase bleeding risk, and ginkgo may add mild antiplatelet effects.
Recommendation: Use cautiously, particularly with anticoagulants, antiplatelet therapy, frequent NSAIDs, bleeding disorders, or upcoming procedures.
Numbered references. Citations throughout the page link here.
Review summarizes pharmacology, efficacy, and noradrenergic adverse effects such as increased pulse and blood pressure.
The review supports avoiding combinations of serotonergic drugs and supplements that increase serotonin production or signaling.
Labeling describes MDD indication, titration, dose limits with strong CYP3A4 inhibitors, blood pressure and heart rate warnings, and MAOI contraindications.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.